Teicoplanin Bradex vs Vancocin: Side-by-Side Comparison
Quick answer: Teicoplanin Bradex and Vancocin are both glycopeptide antibiotic used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Teicoplanin Bradex | Vancocin |
|---|---|---|
| Drug class | Glycopeptide antibiotic | Glycopeptide antibiotic |
| ATC code | J01XA02 | J01XA01 |
| Primary indications | Serious gram-positive infections, MRSA infections | Clostridioides difficile infection, MRSA infections |
| Mechanism | Glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding D-alanyl-D-alanine peptidoglycan precursors | Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of peptidoglycan precursors |
| Common dose | 400 mg IV/IM daily after loading dose | 125-500 mg orally 4 times daily (CDI); 15-20 mg/kg IV every 8-12 hours |
| Detail page | Teicoplanin Bradex details → | Vancocin details → |
How to choose between Teicoplanin Bradex and Vancocin
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Glycopeptide antibiotic on iMedic · Teicoplanin Bradex full details · Vancocin full details
Frequently asked questions
Is Teicoplanin Bradex better than Vancocin?
Neither is universally 'better.' They are both glycopeptide antibiotic with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Teicoplanin Bradex to Vancocin?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Teicoplanin Bradex and Vancocin have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Teicoplanin Bradex and Vancocin available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.